A KARIM PHARMA LTD
🌿Early-stageactive
14618019 · ltd · incorporated 2023-01-26
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
Opportunity decay
approaching window · 12-months
Approaching a transaction window — refinance or sale event plausible in the next 12 months.
- · Oldest live charge 3.1y old — refinance window within 12 months
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Jan 2025
Net worth
£112.0k
book net assets
Opportunity
72/100
Strong
What this business does
Primary activity: Other human health activities
Sector: Human health & social work
Investor take
PursueActive trading company. Family succession underway — not a classic acquisition target.
Opportunity 72/100 (strong), bankability 75/100. Same-surname younger director in place — likely family handover, not open to sale. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Deleverage or restructure. Leverage at 100% of assets — consider sale of non-core assets or equity injection. Most likely exit: strategic trade sale (73/100).
🏦
Refinance opportunity
2 live charges · oldest 3.1y
75/100
ready
Refinance conversation should be productive — structure clean and timing right.
- · Charge age ~3.1 years — mid-life; refi window approaching.
- · Single lender — cleanest path to refinance.
- · Legal-friction score 15/100 — clean.
Data confidence
Overall: high (82/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
2 charges (2/2 with lender, 2/2 with type)
90
Directors & officers
3 officers (3 active, 3 linked, 3 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
6 connected companies via shared directors
63
Filing history
20 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
72/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
60
Adequate — check latest filings for context.
Acquirability
55
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
100
Good data coverage for analysis.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredPositive net assets
Net assets £111,954
High leverage
Liabilities are 100% of total assets
Leverage
100%
Liabilities / Total assets
Key financials
2 years extracted from filed iXBRL accountsCash
—
Net Worth
£112k
↑ 461% YoY
Current Assets
£324k
↑ 22% YoY
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-01-31 | 2024-01-31 |
|---|---|---|
| Total assets | £866.1k | £660.2k |
| Current assets | £323.9k | £266.4k |
| Cash | — | £63.5k |
| Debtors | — | £203.0k |
| Net assets | £112.0k | £19.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
5
filings
- • 4 miscellaneous
- • 1 confirmation-statement
Last 180 days
5
filings
- • 4 miscellaneous
- • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (22 events)Click to expand
- 2026-05-08📄legacymiscellaneous · RPCH01
- 2026-05-08📄legacymiscellaneous · RPCH01
- 2026-04-27📄legacymiscellaneous · RPCH01
- 2026-04-27📄legacymiscellaneous · RPCH01
- 2025-10-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-02-05📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-02-01➕ASEFI, Ahmad appointeddirector
- 2024-10-21📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2023-10-12📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-10-10📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-10-09📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-08-03📄mortgage-create-with-deed-with-charge-number-charge-creation-datemortgage · MR01
- 2023-07-28🔒Charge registered #2Lender: Barclays Security Trustee Limited
- 2023-07-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-07-27📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2023-05-12📄mortgage-create-with-deed-with-charge-number-charge-creation-datemortgage · MR01
- 2023-05-11🔒Charge registered #1Lender: Barclays Security Trustee Limited
- 2023-02-10📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-01-31➕KARIM, Junaid appointeddirector
- 2023-01-26🏢Company incorporatedAs A KARIM PHARMA LTD
- 2023-01-26➕KARIM, Ruckaiya appointeddirector
- 2023-01-26📄incorporation-companyincorporation · NEWINC
Owner dependency
73/100
High — earn-out structure requiredMaterial founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
FACTORS
- +Founder name in company name: Company name contains director surname "KARIM" — strong identity link between founder and business.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Junaid Karim Individual · British · DOB 08/1969 · age 57 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 26/01/2023 |
Miss Ruckaiya Karim Individual · British · DOB 06/1992 · age 34 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 26/01/2023 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · BD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ADNAN LOCUMS LIMITED→ 10848416 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ADVANCE PRACTICE CONSULTING LIMITED→ 16369215 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ADYAN K LTD→ 12341921 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AESTHETIC TOUCH LIMITED→ 06494996 · est 2008 · no financials extracted | — | — | — | — | 18y | — | — |
| AFA IMAGING LTD→ 12874105 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AFIA SOLUTIONS LTD→ 16154775 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AFK HEALTHCARE LIMITED→ 15615219 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE UK BRADFORD DISTRICT LTD→ 02646454 · est 1991 · no financials extracted | — | — | — | — | 34y | — | — |
| AGE UK NORTH CRAVEN→ 07609423 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| AH PHARMS LTD→ 12317218 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AHJ HEARING CARE LIMITED→ 17026448 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AHMED CARES LIMITED→ 08745502 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2023-01-26
Jurisdictionengland-wales
Primary SIC86900 — Other human health activities
Registered office
Osborne House Low Lane
Clayton
Bradford
BD14 6QA
England
Filing status
Accounts
Next due: 2026-10-31
Last made up to: 2025-01-31
Confirmation statement
Next due: 2027-02-24
Last: 2026-02-10
Officers (3 active · 0 resigned)
ASEFI, Ahmad→
Activedirector · ~34y · appointed 2025-02-01
View their other companies + combined net worth →
KARIM, Junaid→
Activedirector · ~57y · appointed 2023-01-31
View their other companies + combined net worth →
KARIM, Ruckaiya→
Activedirector · ~34y · appointed 2023-01-26
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Mortgages & charges
2
Total charges
2
Outstanding
1
Active lenders
Status:Lender:2 of 2 shown
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| outstanding | Barclays Barclays Security Trustee Limited | A registered charge | 1 property | 28/07/2023 | — | |
| outstanding | Barclays Barclays Security Trustee Limited | A registered charge | — | 11/05/2023 | — |
Click column headers to sort. Use filters above to narrow by status and lender.
Recent filings (20 total)
legacy
miscellaneous · RPCH01
2026-05-08
legacy
miscellaneous · RPCH01
2026-05-08
confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-04-28
legacy
miscellaneous · RPCH01
2026-04-27
legacy
miscellaneous · RPCH01
2026-04-27
accounts-with-accounts-type-micro-entity
accounts · AA
2025-10-24
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-02-26
appoint-person-director-company-with-name-date
officers · AP01
2025-02-05
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2024-10-21
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-02-29
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-10-12
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-10-10
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-10-09
mortgage-create-with-deed-with-charge-number-charge-creation-date
mortgage · MR01
2023-08-03
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-07-27